Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease

Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 12; p. 667420
Main Authors Sathe, Swati, Ware, Jen, Levey, Jamie, Neacy, Eileen, Blumenstein, Robi, Noble, Simon, Mühlbäck, Alzbeta, Rosser, Anne, Landwehrmeyer, G Bernhard, Sampaio, Cristina
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into HD research, providing a large, well-characterized, research-engaged cohort with associated clinical data and biosamples that facilitates recruitment into interventional trials and other research studies. Additional studies that use Enroll-HD data and/or biosamples are built into the platform to further research on biomarkers and outcome measures. Enroll-HD is now operating worldwide in 21 countries at 159 clinical sites across four continents-Europe, North America, Latin America, and Australasia-and has recruited almost 25,000 participants, generating a large, rich clinical database with associated biosamples to expedite HD research; any researcher at a verifiable research organization can access the clinical datasets and biosamples from Enroll-HD and nested studies. Important operational features of Enroll-HD include a strong emphasis on standardization, data quality, and protecting participant identity, a single worldwide study protocol, a flexible EDC system capable of integrating multiple studies, a comprehensive monitoring infrastructure, an online portal to train and certify site personnel, and standardized study documents including informed consent forms and contractual agreements.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology
Edited by: Holm Graessner, University Hospital Tübingen, Germany
Reviewed by: Sachchida Nand Rai, University of Allahabad, India; Lauren Byrne, University College London, United Kingdom
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2021.667420